A Protective Vaccine against Chlamydia Genital Infection Using Vault Nanoparticles without an Added Adjuvant
Chlamydia trachomatis genital infection is the most common sexually transmitted bacterial disease, causing a significant burden to females due to reproductive dysfunction. Intensive screening and antibiotic treatment are unable to completely prevent female reproductive dysfunction, thus, efforts hav...
Main Authors: | Janina Jiang, Guangchao Liu, Valerie A. Kickhoefer, Leonard H. Rome, Lin-Xi Li, Stephen J. McSorley, Kathleen A. Kelly |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/5/1/3 |
Similar Items
-
Modulation of the vault protein-protein interaction for tuning of molecular release
by: Yu, Kang, et al.
Published: (2018) -
Winning jumps and pole vault /
by: Jacoby, Ed
Published: (2009) -
Unveiling the uncommon: vault hematoma and vault cellulitis following hysterectomy – a comprehensive narrative review
by: Ipsita Mohapatra, et al.
Published: (2024-03-01) -
Seismic Behavior of Masonry Cloister Vaults
by: Satwant Rihal, et al.
Published: (2018-12-01) -
Reactive Infectious Mucosal Eruptions (RIME) Secondary to <i>Chlamydia pneumoniae</i> Infection
by: Frederik Færgemann Lau, et al.
Published: (2021-05-01)